FundedIQ
Biotechnology

Rebel Medicine: Funding, Investors & Team (Sep 2026)

Rebel Medicine is a company in the early stages of development in the field of life sciences, focusing on creating alternatives for managing pain without opioids. Their products include long-lasting local anesthetic injections for pain after surgery and wound dressings with anesthetic properties for painful skin injuries.

www.rebelmedicine.com LinkedIn Salt Lake City, United States 11-50 employees
Biopharma Health Care Medical
Total raised
$4.9M
Rounds
1
Latest
Series A
Feb 2025

Rebel Medicine has raised $4.9M across 1 funding round on record, the most recent a Series A of $4.9M announced in Feb 2025.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Rebel Medicine Company Profile and Key Stats

Total funding raised
$4.9M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$4.9M in Feb 2025
Employees
11-50
reported band
Headquarters
Salt Lake City, United States

Latest funding round on record: Feb 2025.

Rebel Medicine Funding Rounds

Date
Round
Amount
Series A
$4.9M

Rebel Medicine Founders and Leadership Team

Name
Role
Contact
Caleb Lade
Founder

No contact details are on record for this team yet.

Rebel Medicine Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M
8,378
$15M

Rebel Medicine's latest round of $4.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Rebel Medicine in Biotechnology and Salt Lake City

Companies Similar to Rebel Medicine

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Rebel Medicine Funding FAQs

What does Rebel Medicine do?

Rebel Medicine is a company in the early stages of development in the field of life sciences, focusing on creating alternatives for managing pain without opioids. Their products include long-lasting local anesthetic injections for pain after surgery and wound dressings with anesthetic properties for painful skin injuries.

How much funding has Rebel Medicine raised?

Rebel Medicine has raised $4.9M across 1 round on record. The most recent is a Series A of $4.9M announced in Feb 2025.

When did Rebel Medicine last raise funding?

Rebel Medicine's most recent funding round on record is a Series A of $4.9M, announced in Feb 2025.

Who founded Rebel Medicine?

FundedIQ lists Caleb Lade (Founder) at Rebel Medicine.

Where is Rebel Medicine headquartered?

Rebel Medicine is based in Salt Lake City, Utah, United States.

How many employees does Rebel Medicine have?

Rebel Medicine is in the 11-50 employee band.

How does Rebel Medicine's funding compare to other Biotechnology startups?

Rebel Medicine's latest round of $4.9M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Rebel Medicine Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rebel Medicine is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.